Literature DB >> 6118823

Glutamate as a precursor of GABA in rat brain and peripheral tissues.

H L White.   

Abstract

The formation of GABA from L-glutamate was investigated in homogenates of rat brain, liver, and kidney, using highly purified [14C]-L-glutamic acid as substrate and a thin-layer chromatographic separation of products. In agreement with other workers, liberation of [14C]-CO2 was found to be stoichiometric with GABA formation in brain homogenates, but not in liver or kidney extracts. Subcellular fractionation and dialysis experiments suggested that most of the GABA synthesis in these peripheral tissues, unlike brain, does not occur via a direct decarboxylation of glutamate and requires one or more cofactors other than pyridoxal phosphate. NAD stimulated GABA formation in dialyzed extracts, and inhibition of GABA-transaminase, both in vitro and in vivo, caused marked inhibition of GABA formation from glutamate in peripheral extracts. Although a very low GAD activity in liver and kidney cannot be excluded, these experiments suggest a major pathway from glutamate to GABA in these homogenates which includes (1) conversion of glutamate to alpha-ketoglutarate by glutamate dehydrogenase or transaminases, (2) conversion of alpha-ketoglutarate to succinic semialdehyde, and (3) formation of GABA from succinic semialdehyde and glutamate by GABA-transaminase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6118823     DOI: 10.1007/bf00232578

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  16 in total

1.  The distribution of glutamate decarboxylase in rat tissues; isotopic vs fluorimetric assays.

Authors:  P MacDonnell; O Greengard
Journal:  J Neurochem       Date:  1975-04       Impact factor: 5.372

2.  Some properties of L-glutamic decarboxylase in mouse brain.

Authors:  E ROBERTS; D G SIMONSEN
Journal:  Biochem Pharmacol       Date:  1963-02       Impact factor: 5.858

3.  Purification and characterization of glutamate decarboxylase from mouse brain.

Authors:  J Y Wu; T Matsuda; E Roberts
Journal:  J Biol Chem       Date:  1973-05-10       Impact factor: 5.157

4.  A -aminobutyrate pathway in mammalian kidney cortex.

Authors:  G Lancaster; F Mohyuddin; C R Scriver; D T Whelan
Journal:  Biochim Biophys Acta       Date:  1973-02-28

5.  An artifact in the radiochemical assay of brain mitochondrial glutamate decarboxylase.

Authors:  L P Miller; D L Martin
Journal:  Life Sci       Date:  1973-10-01       Impact factor: 5.037

6.  Brain glutamate decarboxylase: changes in the developing rat brain.

Authors:  K L Sims; F N Pitts
Journal:  J Neurochem       Date:  1970-11       Impact factor: 5.372

7.  L-glutamic acid decarboxylase in non-neural tissues of the mouse.

Authors:  R J Drummond; A T Phillips
Journal:  J Neurochem       Date:  1974-12       Impact factor: 5.372

8.  Hydrazinopropionic acid: a new inhibitor of aminobutyrate transaminase and glutamate decarboxylase.

Authors:  N M van Gelder
Journal:  J Neurochem       Date:  1968-08       Impact factor: 5.372

9.  Stoichiometry of GABA and CO2 formation in glutamate decarboxylase assays: alteration by an impurity L-U-[14C] glutamate.

Authors:  A M Morin; C G Wasterlain
Journal:  J Neurochem       Date:  1978-07       Impact factor: 5.372

10.  Glutamate decarboxylase (GAD) and gamma-aminobutyric acid (GABA) in discrete nuclei of hypothalamus and substantia nigra.

Authors:  M L Tappaz; M J Brownstein; I J Kopin
Journal:  Brain Res       Date:  1977-04-08       Impact factor: 3.252

View more
  7 in total

1.  Presynaptic modulation by L-glutamate and GABA of sympathetic co-transmission in rat isolated vas deferens.

Authors:  Y W Kwan; M P Ngan; K Y Tsang; H M Lee; L A Chu
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

2.  Deletion of the γ-aminobutyric acid transporter 2 (GAT2 and SLC6A13) gene in mice leads to changes in liver and brain taurine contents.

Authors:  Yun Zhou; Silvia Holmseth; Caiying Guo; Bjørnar Hassel; Georg Höfner; Henrik S Huitfeldt; Klaus T Wanner; Niels C Danbolt
Journal:  J Biol Chem       Date:  2012-08-15       Impact factor: 5.157

Review 3.  Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation.

Authors:  Osama A Abulseoud; Fawaz Alasmari; Abdelaziz M Hussein; Youssef Sari
Journal:  Front Neurosci       Date:  2022-07-05       Impact factor: 5.152

4.  Toxic effects of methoxychlor in rat striatum: modifications in several neurotransmitters.

Authors:  A Lafuente; T Cabaleiro; A Caride; A Gutiérrez; A I Esquifino
Journal:  J Physiol Biochem       Date:  2007-06       Impact factor: 4.158

5.  Biochemical, histopathological and morphological profiling of a rat model of early immune stimulation: relation to psychopathology.

Authors:  Anna Kubesova; Hana Tejkalova; Kamila Syslova; Petr Kacer; Jana Vondrousova; Filip Tyls; Michaela Fujakova; Tomas Palenicek; Jiri Horacek
Journal:  PLoS One       Date:  2015-01-20       Impact factor: 3.240

6.  Hepatocyte membrane potential regulates serum insulin and insulin sensitivity by altering hepatic GABA release.

Authors:  Caroline E Geisler; Susma Ghimire; Chelsea Hepler; Kendra E Miller; Stephanie M Bruggink; Kyle P Kentch; Mark R Higgins; Christopher T Banek; Jun Yoshino; Samuel Klein; Benjamin J Renquist
Journal:  Cell Rep       Date:  2021-06-29       Impact factor: 9.423

7.  A critical role of hepatic GABA in the metabolic dysfunction and hyperphagia of obesity.

Authors:  Caroline E Geisler; Susma Ghimire; Stephanie M Bruggink; Kendra E Miller; Savanna N Weninger; Jason M Kronenfeld; Jun Yoshino; Samuel Klein; Frank A Duca; Benjamin J Renquist
Journal:  Cell Rep       Date:  2021-06-29       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.